Scorpius Holdings Reports Material Agreement and Equity Sales
Ticker: SCPX · Form: 8-K · Filed: Sep 19, 2025 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $471,000, $150,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
Related Tickers: SCPX
TL;DR
Scorpius Holdings inked a deal, sold stock, and took on debt on Sept 12th.
AI Summary
On September 12, 2025, Scorpius Holdings, Inc. entered into a material definitive agreement and incurred a direct financial obligation. The company also reported unregistered sales of equity securities. The filing includes financial statements and exhibits.
Why It Matters
This filing indicates significant financial activity for Scorpius Holdings, including new agreements and the issuance of equity, which could impact its financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements, financial obligations, and unregistered equity sales, suggesting potential financial shifts and dilution risks.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- September 12, 2025 (date) — Date of earliest event reported
- NightHawk Biosciences, Inc. (company) — Former company name
- HEAT BIOLOGICS, INC. (company) — Former company name
FAQ
What type of material definitive agreement did Scorpius Holdings, Inc. enter into?
The filing indicates Scorpius Holdings, Inc. entered into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 12, 2025.
What other items are reported in this 8-K filing besides the material definitive agreement?
The filing also reports the creation of a direct financial obligation, unregistered sales of equity securities, and includes financial statements and exhibits.
What were Scorpius Holdings, Inc.'s former company names?
Scorpius Holdings, Inc.'s former company names were NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.
What is the SIC code for Scorpius Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Scorpius Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 793 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2025-09-18 21:37:17
Key Financial Figures
- $471,000 — r Hundred Seventy-One Thousand Dollars ($471,000) to an institutional investor (the "Hol
- $150,000 — fails to pay indebtedness in excess of $150,000 due to any third party, subject to cert
Filing Documents
- scpx_8k.htm (8-K) — 27KB
- ex4z1.htm (EX-4.1) — 36KB
- 0001079973-25-001479.txt ( ) — 230KB
- scpx-20250912.xsd (EX-101.SCH) — 3KB
- scpx-20250912_lab.xml (EX-101.LAB) — 33KB
- scpx-20250912_pre.xml (EX-101.PRE) — 22KB
- scpx_8k_htm.xml (XML) — 3KB
01. Entry Into a Material Definitive Agreement
Item 1.01. Entry Into a Material Definitive Agreement. On September 12, 2025, Scorpius Holdings, Inc., a Delaware corporation (the "Company"), issued a non-convertible promissory note (the "Note") in the principal amount of Four Hundred Seventy-One Thousand Dollars ($471,000) to an institutional investor (the "Holder"). The Note accrues interest at the rate of 5.0% per annum and matures on the earlier of: (i) October 31, 2025; (ii) the consummation of a Corporate Event (as such term is defined in the Note); or (iii) when, upon or after the occurrence of an event of default under the Note. All payments by the Company upon maturity, redemption or prepayment of the Note shall include, together with all other amounts of principal and/or interest, a premium payment equal to 5% of the principal amount of the Note. The Note contains customary events of default, including if the Company or any of its subsidiaries, individually or in the aggregate, fails to pay indebtedness in excess of $150,000 due to any third party, subject to certain exceptions, or if an event of default occurs under any other outstanding promissory note of the Company. If at any time the Note is outstanding the Company consummates a subsequent Financing (as such term is defined in the Note), the Holder shall have the right, it its sole discretion, to require that the Company redeem the entire outstanding balance of the Note, together with all accrued interest thereon, using up to 100% of the gross proceeds of such Financing. The Company sold the Note in reliance upon an exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended and/or Regulation D promulgated thereunder. The foregoing description of the Note is qualified in its entirety by reference to the full text of the Note, a copy of which is attached hereto as Exhibit 4.1, and which is incorporated herein in its entirety by reference.
03. Creation of a Direct Financial Obligation
Item 2.03. Creation of a Direct Financial Obligation or an Obligation Under an Off-balance Sheet Arrangement of a Registrant. The information set forth under Item 1.01 above of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.
02. Unregistered
Item 3.02. Unregistered Sales of Equity Securities. The information set forth under Item 1.01 above of this Current Report on Form 8-K is incorporated by reference in this Item 3.02. The Note was issued pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder. The Note may not be offered or sold in the United States in the absence of an effective registration statement or exemption from the registration requirements.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 4.1 Form of Promissory Note 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 18, 2025 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer